NImmune Biopharma, a late-clinical-stage precision immunology biopharmaceutical company that develops novel biomarker-driven immunoregulatory therapeutics, has entered a research collaboration with BioTherapeutics Inc., a clinical-stage biotech company that combines advanced computational modeling with translational and clinical experimentation to accelerate the development of novel products.   The collaboration strengthens NImmune’s precision immunology capabilities by providing access to Bio...